1994b The Washington, DC, Metropolitan Area Drug Study: Prevalence of Drug Use in the DC Metropolitan Area Household and Nonhousehold Populations: 1991 (Technical Report #8). Rockville, MD: National Institute on Drug Abuse.

1994c Current Treatment Client Characteristics in the Washington DC Metropolitan Area, 1991. Technical Report #5. Rockville, MD: National Institute on Drug Abuse.

Office of Technology Assessment 1990 The Effectiveness of Drug Abuse Treatment: Implications for Controlling AIDS/HIV Infection. (Report Number 052-003-0120-3). Washington, DC: U.S. Government Printing Office.

O'Malley, P.M. Unpublished data from the Monitoring the Future Project, Institute for Social Research, University of Michigan .

Ouellet, L., A.D. Jimenez, and W.W. Wiebel 1993 Heroin Again: New Users of Heroin in Chicago. Society for the Study of Social Problems, Miami Beach, August 11-13.

Prevots, D.R., D.M. Allen, J.S. Lehman, T.A. Green, L.R. Petersen, and M. Gwinn 1995 Trends in Seroprevalence Among Injection Drug Users Entering Drug Treatment Centers, United States, 1988-1993. Paper presented at the Second National Conference on Human Retroviruses and Related Infections, American Society for Microbiology, Washington, D.C.

Schuster, C.R. 1988 Intravenous drug use and AIDS prevention. Public Health Reports 103(3):281-286.

Selwyn, P.A., C. Feiner, C.P. Cox, C. Lipshutz, and R.L. Cohen 1987 Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City. AIDS 1(4):247-254.

Siegal, H.A., R.G. Carlson, R.S. Falck, and J. Wang 1995 Drug abuse treatment experience and HIV risk behaviors among active drug injectors in Ohio. American Journal of Public Health 85(1):105-108.

Spencer, B.D. 1989 On the accuracy of current estimates of the numbers of intravenous drug users. Pp. 429-446 in AIDS: Sexual Behavior and Intravenous Drug Use, C.F. Turner, H.G. Miller, and L.E. Moses, eds. Washington DC: National Academy Press.

Turner, C.F., H.G. Miller, and L.E. Moses, eds. 1989 AIDS: Sexual Behavior and Intravenous Drug Use. Washington, DC: National Academy Press.

U.S. General Accounting Office 1993 Drug Use Measurement: Strengths, Limitations, and Recommendations for Improvement (Report prepared for the Chairman, Committee on Government Operations, U.S. House of Representatives, GAO/PEMD-93-18). Washington, DC: U.S. General Accounting Office.

Vlahov, D., and B.F. Polk 1988 Intravenous drug users and human immunodeficiency virus infection in prison. AIDS Public Policy Journal 3:42-46.

Vlahov, D., T.F. Brewer, K.G. Castro, J.P. Narkunas, M.E. Salive, J. Ullrich, and A. Muñoz 1991a Prevalence of antibody to HIV-1 among entrants to U.S. correctional facilities. Journal of the American Medical Association 265:1129-1132.

Vlahov, D., J.C. Anthony, D. Celentano, L. Solomon, and N. Chowdhury 1991b Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987 . American Journal of Drug and Alcohol Abuse 17:39-48.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement